Miller/Nadler Glare Tester
510(k) K832762
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK832762 | Date29 Sep 1983 | StatusActive |
Recalls
No FDA recalls found in the data synced 6 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- HLX
- Device Class
- Class II
- Regulation
- 21 CFR Part 886.1630
- Advisory Committee
- Ophthalmic
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 26 Sep 2026
The Miller/Nadler Glare Tester is an AC-powered photostimulator designed for ophthalmic use. It functions as a clinical instrument to evaluate visual acuity in the presence of glare, particularly for patients with cataracts or posterior capsule opacification.
This device is identified by product code HLX and is regulated under 21 CFR 886.1630 as a Class 2 medical device. It received FDA 510(k) clearance on September 29, 1983, under K832762. The device is manufactured by Titmus Optical, Inc.
Other devices from Titmus Optical, Inc.
Questions
AI-generated answers, 26 Sep 2026
What is the primary clinical use of the Miller/Nadler Glare Tester?
This device is a clinical instrument designed to assess a patient's visual acuity while they are exposed to glare. It is specifically used to evaluate visual function in patients who have cataracts or posterior capsule opacification.
How is the Miller/Nadler Glare Tester powered?
The device is an AC-powered photostimulator, meaning it requires a standard alternating current electrical connection to function during ophthalmic examinations.
What is the regulatory status of this device?
The Miller/Nadler Glare Tester is classified as a Class 2 medical device under 21 CFR 886.1630. It received FDA 510(k) clearance on September 29, 1983, under submission number K832762.